Biocodex Introduces Fullify™, a First-of-Its-Kind Precision Probiotic Clinically Shown to Activate the Gut-Brain Pathway to Support Appetite Management
In a supplement category long dominated by stimulants, appetite suppressants and short-term fixes, Biocodex is introducing a fundamentally different approach. The science-driven health & wellness company behind Florastor® recently announced the U.S. launch of Fullify™, a first-of-its-kind precision probiotic developed to support appetite management and weight loss by working with the body’s natural gut-brain signaling.
Biocodex Invests up to €30 Million in MRM Health, a Belgian Microbiome Therapy Innovator
Biocodex, a French family-owned pharmaceutical pioneer in microbiota research for over 70 years, announces a strategic equity investment of €11 million in MRM Health, a Belgian clinical-stage biotech developing innovative microbiome-based therapeutics for inflammatory diseases and immune-oncology. The total partnership could reach approximately €30 million, reflecting Biocodex’s long-term commitment to advancing new therapeutic approaches.
